Jeito Capital Co-Leads $76 Million Series A Financing for CDR-Life, its 10th Investment Since its Launch

PARIS--(BUSINESS WIRE)--Jeito Capital ("Jeito"), a leading independent Private Equity firm dedicated to biotech and biopharma, announced today that it has co-led a $76 million Series A financing round in CDR-Life, a privately-held biotech company developing a new generation of immuno-oncology therapies. Jeito co-led the financing within a strong international syndicate, with RA Capital Management and the participation of Omega Fund Management, as the third investor in this round. Following the

Full Story →